Price T Rowe Associates Inc Axogen, Inc. Transaction History
Price T Rowe Associates Inc
- $836 Billion
- Q2 2024
A detailed history of Price T Rowe Associates Inc transactions in Axogen, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 31,173 shares of AXGN stock, worth $415,847. This represents 0.0% of its overall portfolio holdings.
Number of Shares
31,173
Previous 29,650
5.14%
Holding current value
$415,847
Previous $240,000
5.83%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding AXGN
# of Institutions
130Shares Held
35.8MCall Options Held
79.1KPut Options Held
500-
Arrow Mark Colorado Holdings LLC Denver, CO5.12MShares$68.3 Million0.49% of portfolio
-
First Light Asset Management, LLC Edina, MN3.34MShares$44.6 Million2.2% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT3.31MShares$44.1 Million2.42% of portfolio
-
Black Rock Inc. New York, NY3.25MShares$43.3 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.52MShares$33.6 Million0.0% of portfolio
About Axogen, Inc.
- Ticker AXGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 42,283,700
- Market Cap $564M
- Description
- AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...